Print

MaxCyte, Inc. Presents Unprecedented CHO-Based Transient Gene Expression Data for Gram Scale Antibody Production and Rapid Stable Cell Line Generation at CHI’s 2013 Protein and Antibody Engineering Summit (PEGS)  
4/26/2013 9:09:49 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MaxCyte, Inc., the pioneer in scalable, high performance cell transfection systems, is hosting a series of events at Cambridge Health Institute’s PEGS Summit, the premier conference in the protein and antibody biotherapeutic arena, being held April 29 – May 3 in Boston, MA. During the conference, MaxCyte will present break-through transient gene expression (TGE) data in a scientific podium presentation and detail unmatched antibody production capabilities in two technical posters.

Help employers find you! Check out all the jobs and post your resume.

//-->